These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 30281083)

  • 21. Malaria prevention recommendations for risk groups visiting sub-Saharan Africa: A survey of European expert opinion and international recommendations.
    Shellvarajah M; Hatz C; Schlagenhauf P
    Travel Med Infect Dis; 2017 Sep; 19():49-55. PubMed ID: 28939502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A systematic review and meta-analysis of the effectiveness and safety of atovaquone proguanil (Malarone) for chemoprophylaxis against malaria.
    Nakato H; Vivancos R; Hunter PR
    J Antimicrob Chemother; 2007 Nov; 60(5):929-36. PubMed ID: 17848375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reported side effects to chloroquine, chloroquine plus proguanil, and mefloquine as chemoprophylaxis against malaria in Danish travelers.
    Petersen E; Ronne T; Ronn A; Bygbjerg I; Larsen SO
    J Travel Med; 2000; 7(2):79-84. PubMed ID: 10759574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malaria protection in Sierra Leone during the Ebola outbreak 2014/15; The UK military experience with malaria chemoprophylaxis Sep 14-Feb 15.
    Tuck J; Williams J
    Travel Med Infect Dis; 2016; 14(5):471-474. PubMed ID: 27474994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atovaquone and proguanil hydrochloride: a review of nonclinical studies.
    Pudney M; Gutteridge W; Zeman A; Dickins M; Woolley JL
    J Travel Med; 1999 May; 6 Suppl 1():S8-12. PubMed ID: 23573546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review: Malaria chemoprophylaxis for travelers to Latin America.
    Steinhardt LC; Magill AJ; Arguin PM
    Am J Trop Med Hyg; 2011 Dec; 85(6):1015-24. PubMed ID: 22144437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The conundrum of malaria chemoprophylaxis.
    Shanks D
    J Travel Med; 2016 Jun; 23(6):. PubMed ID: 27694470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recognition and Management of Malaria.
    Gerstenlauer C
    Nurs Clin North Am; 2019 Jun; 54(2):245-260. PubMed ID: 31027664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Problems in prescribing malaria chemoprophylaxis for travelers.
    Dupouy-Camet J; Yera H; Tourte-Schaeffer C
    Fundam Clin Pharmacol; 2003 Apr; 17(2):161-9. PubMed ID: 12667226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malaria prophylaxis for aircrew: safety of atovaquone/proguanil in healthy volunteers under aircraft cabin pressure conditions.
    Simons R; Valk PJ; Krul AJ
    J Travel Med; 2005; 12(4):210-6. PubMed ID: 16086896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Knowledge, attitudes, and practices regarding antimalarial chemoprophylaxis in U.S. Peace Corps Volunteers--Africa, 2013.
    Landman KZ; Tan KR; Arguin PM;
    MMWR Morb Mortal Wkly Rep; 2014 Jun; 63(23):516-7. PubMed ID: 24918487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.
    McKeage K; Scott L
    Drugs; 2003; 63(6):597-623. PubMed ID: 12656656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-free holidays: pre-travel versus during travel malaria chemoprophylaxis.
    Shanks GD; Magill AJ; Freedman DO; Keystone JS; Bradley DJ; Steffen R
    Am J Trop Med Hyg; 2007 Jul; 77(1):1-2. PubMed ID: 17620622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malaria Prevention Strategies: Adherence Among Boston Area Travelers Visiting Malaria-Endemic Countries.
    Stoney RJ; Chen LH; Jentes ES; Wilson ME; Han PV; Benoit CM; MacLeod WB; Hamer DH; Barnett ED;
    Am J Trop Med Hyg; 2016 Jan; 94(1):136-42. PubMed ID: 26483125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malaria chemoprophylaxis in UK general practitioners traveling to South Asia.
    Banerjee D; Stanley PJ
    J Travel Med; 2001; 8(4):173-5. PubMed ID: 11712503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the potential for discontinuing atovaquone-proguanil (AP) ad-hoc post-exposure and other abbreviated AP-regimens: Pharmacology, pharmacokinetics and perspectives.
    Schnyder JL; de Jong HK; Bache EB; van Hest RM; Schlagenhauf P; Borrmann S; Hanscheid T; Grobusch MP
    Travel Med Infect Dis; 2023; 52():102520. PubMed ID: 36526126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monthly sulphadoxine-pyrimethamine combination versus daily proguanil for malaria chemoprophylaxis in sickle cell disease: a randomized controlled study at the Jos University Teaching Hospital.
    Dawam JA; Madaki JKA; Gambazai AA; Okpe ES; Lar-ndam N; Onu A; Gyang M
    Niger J Med; 2016; 25(2):119-27. PubMed ID: 29944308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A cluster of Plasmodium vivax malaria in an expedition group to Ethiopia: prophylactic efficacy of atovaquone/proguanil on liver stages of P. vivax.
    Mavrogordato A; Lever AM
    J Infect; 2012 Sep; 65(3):269-74. PubMed ID: 22609735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atovaquone/proguanil: the need for family protection.
    Kain KC
    J Travel Med; 2003 May; 10 Suppl 1():S8-12; discussion S21. PubMed ID: 12737754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atovaquone-proguanil (malarone): an effective treatment for uncomplicated Plasmodium falciparum malaria in travelers from Denmark.
    Thybo S; Gjorup I; Ronn AM; Meyrowitsch D; Bygberg IC
    J Travel Med; 2004; 11(4):220-3. PubMed ID: 15541224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.